Vetoquinol acquires the rights for Profender® from Elanco animal health for Canada

February 8th, 2021 (Lure, France) - Vetoquinol announced today the acquisition of the Canadian rights to Profender® product family from Elanco Animal Health.

Vetoquinol has acquired the Profender® product family, the intellectual property, registrations and other rights from Elanco Animal Health for the Canadian market. This acquisition has been approved by the Canadian Competion Bureau. The Profender® range consists in spot-on de-wormer products for cats.

In August 2020, Vetoquinol acquired the Profender® and Drontal® product families in the EU and the UK in relation to Elanco’s 2020 acquisition of Bayer AG’s animal health business. In January 2021, Vetoquinol also acquired the Profender® and Drontal® product families in Australia.

Matthieu Frechin, CEO of Vetoquinol, said: "We are very pleased to acquire Profender® for the Canadian market, one of our prominent strategic countries. The acquisition of this strong brand for the Canadian market confirms our ambition to become a major player in the parasiticide segment. Adding this Essential to our product portfolio in Canada will strengthen our market share in the pet segment in this strategic country.”

Press release